Samuel D Waksal

Title: The Innovations of Samuel D. Waksal

Introduction

Samuel D. Waksal is a prominent inventor based in New York, NY (US). He holds a total of 4 patents that reflect his contributions to the pharmaceutical field. His work primarily focuses on developing innovative solutions for medical conditions, particularly those related to copper accumulation in the body and immunomodulation.

Latest Patents

Waksal's latest patents include formulations for stable trientine, which are pharmaceutical dosage forms designed to treat diseases such as Wilson's disease. These formulations utilize sealed packaging that provides high barrier protection against air, moisture, and light, thereby preventing the drug from decomposing. Another significant patent involves immunomodulatory agents that consist of antibodies specifically binding to PD-L1. These agents are designed to inhibit PD-L1-mediated immunosuppression, enhancing cell and cytokine-mediated immunity for treating neoplastic and infectious diseases.

Career Highlights

Throughout his career, Waksal has made significant strides in the pharmaceutical industry. He has worked with notable companies such as Kadmon Corporation and Kadmon Pharmaceuticals. His innovative approaches have led to advancements in treatments that address critical health issues.

Collaborations

Waksal has collaborated with several professionals in his field, including Zhenping Zhu and Yan Wu. These partnerships have contributed to the development of his patented technologies and have furthered research in immunotherapy and pharmaceutical formulations.

Conclusion

Samuel D. Waksal's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of diseases, showcasing the importance of innovation in healthcare.